Both in Pharmaceuticals
BioMarin Pharmaceuticals vs Arrowhead Research
Over the past year BMRN returned +2.6% and ARWR returned +51.9%; their daily moves had a correlation of 0.20.
BMRN +2.6% ARWR +51.9%Growth of $1, one year, split-adjusted
| Metric | BMRN | ARWR |
|---|---|---|
| Price | $54.68 | $55.90 |
| Market cap | $10.58B | $7.90B |
| Today | −2.44% | −4.44% |
| 1 month | −16.0% | −17.5% |
| 6 months | +0.1% | −19.6% |
| Year to date | −8.0% | −15.8% |
| 1 year | +3.0% | +46.4% |
| Revenue growth (YoY) | +19.9% | +171.0% |
| Gross margin | 79.5% | 100.0% |
| Net margin | 4.5% | −258.2% |
| P/E (TTM) | 145.1× | — |
| Price / sales | 3.1× | 11.8× |
| Net cash | -$3.31B | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 30.8% | 46.0% |
| Short % of float | 6.0% | 7.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).